Sustainable Innovation Leverage ACC’s PyroSmart NextGen recombinant LAL technology as a sustainable alternative to animal-based reagents for endotoxin testing, targeting pharmaceutical and biotech customers seeking greener QA solutions and reduced animal content.

Regulatory Leadership Position ACC’s ISO 13485 certified, FDA-inspected, and CLIA-certified CTS and diagnostic services as trusted partners for GMP-compliant endotoxin and (1→3)-ß-D-glucans testing across Pharmaceuticals, Medical Devices, and Dialysis markets to expedite new product validations.

Global Reach Capitalize on ACC’s international footprint—U.S. headquarters, European office and NL warehouse—to offer regionalized supply, faster regulatory support, and multi-market testing services for global manufacturers.

Integrated Services Cross-sell CPTS testing, method development, and depyrogenation control design with the core reagents to provide end-to-end endotoxin programs, including Low Endotoxin Recovery studies, enhancing customer lifecycle value.

Clinical Diagnostics Upsell Promote the CLIA-certified Fungitell- and ß-D-glucan testing capabilities to hospitals and clinical labs as rapid fungal infection diagnostics, expanding into in-house testing or referral partnerships for patient care pathways.